The MAGIA partners are glad to announce the publication of their international market studies. The first study concerns the Chinese Medtech Industry. For the four clusters partners these studies are vital element, as they build the first information basis for their SMEs in order to better understand and, subsequently, make an assessment on their opportunities in the target market. China and the US, both countries selected by the SMEs’ groups, not only differ greatly from each other, but also from the European countries of origin of the SMEs. Regulatory requirements, access to health care providers, and reimbursement systems are just a few of the topics that vary from the European healthcare systems.